Comments
Loading...

Oramed Pharmaceuticals

ORMPNASDAQ
Logo brought to you by Benzinga Data
$2.35
-0.06-2.49%
At Close: -
$2.33
-0.02-0.85%
After Hours: Oct 4, 8:37 AM EDT
15 minutes delayed
50%
Overview Rating
Speculative
Technicals Analysis
33
0100
Financials Analysis
60
0100

Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Quotes, Forecast and News Summary

Oramed Pharmaceuticals Stock (NASDAQ: ORMP) stock price, news, charts, stock research, profile.

Open$2.41
Close$2.35
Volume / Avg.77.57K / 100.61K
Day Range$2.35 - $2.41
52 Wk Range1.67 - 3.67
Market Cap$94.99M
P/E Ratio4.72
Dividend Yield-
ExchangeNASDAQ
RSI
47
Short Interest
0.96%
Days to Cover3.45

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ORMP
SCYX

FAQ

Q

How do I buy Oramed Pharmaceuticals (ORMP) stock?

A

You can purchase shares of Oramed Pharmaceuticals (NASDAQ:ORMP) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Oramed Pharmaceuticals (ORMP) competitors?

Q

What is the forecast, or price target, for Oramed Pharmaceuticals (ORMP) stock?

A

Oramed Pharmaceuticals has a consensus price target of $17.33.

Q

What is the current price for Oramed Pharmaceuticals (ORMP)?

A

The stock price for Oramed Pharmaceuticals (NASDAQ: ORMP) is $2.33 last updated October 4, 2024 at 8:37 AM EDT.

Q

Does Oramed Pharmaceuticals (ORMP) pay a dividend?

A

There are no upcoming dividends for Oramed Pharmaceuticals.

Q

When is Oramed Pharmaceuticals (NASDAQ:ORMP) reporting earnings?

A

Oramed Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 7, 2024.

Q

Is Oramed Pharmaceuticals (ORMP) going to split?

A

There is no upcoming split for Oramed Pharmaceuticals.

Q

What sector and industry does Oramed Pharmaceuticals (ORMP) operate in?

A

Oramed Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch